Abpro Bio Statistics

Total Valuation

Abpro Bio has a market cap or net worth of KRW 140.07 billion. The enterprise value is 151.23 billion.

Market Cap	140.07B
Enterprise Value	151.23B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Abpro Bio has 284.69 million shares outstanding. The number of shares has increased by 3.16% in one year.

Current Share Class	n/a
Shares Outstanding	284.69M
Shares Change (YoY)	+3.16%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.21%
Owned by Institutions (%)	0.45%
Float	264.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.49
PB Ratio	1.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.50
EV / Sales	8.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.84

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.16.

Current Ratio	1.98
Quick Ratio	0.46
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-1.74
Interest Coverage	-4.95

Financial Efficiency

Return on equity (ROE) is -15.59% and return on invested capital (ROIC) is -5.44%.

Return on Equity (ROE)	-15.59%
Return on Assets (ROA)	-5.10%
Return on Capital (ROIC)	-5.44%
Revenue Per Employee	364.40M
Profits Per Employee	-395.33M
Employee Count	51
Asset Turnover	0.12
Inventory Turnover	0.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.91%
50-Day Moving Average	498.30
200-Day Moving Average	506.96
Relative Strength Index (RSI)	40.55
Average Volume (20 Days)	1,444,660

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abpro Bio had revenue of KRW 18.58 billion and -20.16 billion in losses. Loss per share was -71.27.

Revenue	18.58B
Gross Profit	-696.17M
Operating Income	-12.69B
Pretax Income	-20.17B
Net Income	-20.16B
EBITDA	-10.80B
EBIT	-12.69B
Loss Per Share	-71.27

Full Income Statement

Balance Sheet

The company has 7.88 billion in cash and 19.04 billion in debt, giving a net cash position of -11.16 billion or -39.21 per share.

Cash & Cash Equivalents	7.88B
Total Debt	19.04B
Net Cash	-11.16B
Net Cash Per Share	-39.21
Equity (Book Value)	122.67B
Book Value Per Share	430.88
Working Capital	24.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.66 billion and capital expenditures -6.26 billion, giving a free cash flow of -10.93 billion.

Operating Cash Flow	-4.66B
Capital Expenditures	-6.26B
Free Cash Flow	-10.93B
FCF Per Share	-38.38

Full Cash Flow Statement

Margins

Gross margin is -3.75%, with operating and profit margins of -68.29% and -108.49%.

Gross Margin	-3.75%
Operating Margin	-68.29%
Pretax Margin	-108.55%
Profit Margin	-108.49%
EBITDA Margin	-58.10%
EBIT Margin	-68.29%
FCF Margin	-58.79%

Dividends & Yields

Abpro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.16%
Shareholder Yield	-3.16%
Earnings Yield	-14.49%
FCF Yield	-7.80%

Stock Splits

The last stock split was on August 21, 2017. It was a reverse split with a ratio of 0.2.

Last Split Date	Aug 21, 2017
Split Type	Reverse
Split Ratio	0.2

Scores

Abpro Bio has an Altman Z-Score of 1.84. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.84
Piotroski F-Score	n/a